![]()
Dr. Bin Su, a professor in the Department of Chemistry and a member of the Center for Gene Regulation in Health and Disease (GRHD), has been awarded a three-year, $445,500 grant from the National Institutes of Health to continue his work developing potential treatments for glioblastoma, an invasive and highly malignant brain tumor. The grant, awarded by the National Institute of Neurological Disorders and Stroke (NINDS), is titled “Enhancement of BBB Crossing of AR Degraders in GBM.” Dr. Su’s lab has identified drug candidates that selectively inhibit the androgen receptor (AR) protein that contributes to glioblastoma progression. These small molecule drug compounds can cross the blood brain barrier (BBB), which is of critical importance to their effectiveness in treating glioblastoma. Learn More » |
||||||||||||||
| FEATURED STORIES | ||||||||||||||
|
| ||||||||||||||
| INNOVATION & TECH TRANSFER NEWS | ||||||||||||||
|
| ||||||||||||||
| LINKS | ||||||||||||||
|
||||||||||||||
|